Organic redox-initiated polymerization process for the fabrication of hydrogels for colon-specific drug delivery

被引:33
|
作者
Akala, EO [1 ]
Elekwachi, O [1 ]
Chase, V [1 ]
Johnson, H [1 ]
Lazarre, M [1 ]
Scott, K [1 ]
机构
[1] Howard Univ, Dept Pharmaceut Sci, Sch Pharm, Washington, DC 20059 USA
关键词
organic-redox initiated polymerization; hydrogels; benzoyl peroxide; N-phenyldiethanolamine;
D O I
10.1081/DDC-120018373
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Organic-redox initiated polymerization technique based on the co-initiators system comprising benzoyl peroxide and N-phenyldiethanolamine was used at ambient temperature to fabricate pH-responsive hydrogels. The effects, of changes in the concentration of the co-initiators system, the ratio in which the co-initiators combined, the type of the polymerization solvent, the pH of the hydrating medium, the concentration of the cross-linking agent based on azo-bond and the pH-sensitive cross-linking agent on the properties of the hydrogels were investigated. Increasing the concentration of the co-initiators system, decreasing the concentration of the two types of cross-linking agents, and replacing DMSO by ethanol as the polymerization solvent resulted in hydrogels with increased equilibrium swelling ratio and increased molecular weight between cross-links at pH 7.4. Increasing the concentration of N-phenyldiethanolamine while keeping the concentration of benzoyl peroxide constant gave hydrogels with increased equilibrium swelling ratios. The equilibrium swelling ratios of the hydrogels at pH 2.0 were not affected by the factors investigated. The polymerization technique may be suitable for the design of drug delivery systems containing thermolabile bioactive agents like peptides and proteins.
引用
收藏
页码:375 / 386
页数:12
相关论文
共 50 条
  • [31] Use of azo polymers for colon-specific drug delivery
    VandenMooter, G
    Maris, B
    Samyn, C
    Augustijns, P
    Kinget, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) : 1321 - 1327
  • [32] Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system
    Chiu, HC
    Hsiue, GH
    Lee, YP
    Huang, LW
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1999, 10 (05) : 591 - 608
  • [33] Development of pH sensitive polyacrylic acid grafted hemicellulose hydrogels for colon-specific controlled drug delivery
    Zhou, Xuesong
    Li, Weibin
    Si, Jinghang
    JOURNAL OF CONTROLLED RELEASE, 2017, 259 : E161 - E161
  • [34] The relation between swelling properties and cross-linking of hydrogels designed for colon-specific drug delivery
    Mahkam, M
    Doostie, L
    DRUG DELIVERY, 2005, 12 (06) : 343 - 347
  • [35] Synthesis and properties of degradable hydrogels of konjac glucomannan grafted acrylic acid for colon-specific drug delivery
    Chen, LG
    Liu, ZL
    Zhuo, RX
    POLYMER, 2005, 46 (16) : 6274 - 6281
  • [36] Smart nanocomposite hydrogels based on azo crosslinked graphene oxide for oral colon-specific drug delivery
    Hou, Lin
    Shi, Yuyang
    Jiang, Guixiang
    Liu, Wei
    Han, Huili
    Feng, Qianhua
    Ren, Junxiao
    Yuan, Yujie
    Wang, Yongchao
    Shi, Jinjin
    Zhang, Zhenzhong
    NANOTECHNOLOGY, 2016, 27 (31)
  • [37] Synthesis and properties of degradable hydrogels of konjac glucomannan grafted acrylic acid for colon-specific drug delivery
    Chen, Li-Gui
    Liu, Zhi-Lan
    Zhuo, Ren-Xi
    Polymer, 16 (6274-6281):
  • [38] Dextran hydrogels for colon-specific drug delivery .5. Degradation in human intestinal incubation models
    Simonsen, L
    Hovgaard, L
    Mortensen, PB
    Brondsted, H
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 3 (06) : 329 - 337
  • [39] Oral colon-specific drug delivery system and its preparation
    Wu, Qingxi
    Yao, Shanjing
    Huagong Xuebao/CIESC Journal, 2013, 64 (01): : 210 - 222
  • [40] Oral colon-specific drug delivery of protein and peptide drugs
    Sinha, V. R.
    Singh, Asmita
    Kumar, Ruchita V.
    Singh, Sanjay
    Kumria, Rachana
    Bhinge, J. R.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2007, 24 (01): : 63 - 92